NASDAQ OMX

Reselling Microsoft 365: New Opportunities with Microsoft's Visionary New Platform, AppRiver says

Dela

 

 

NOTE: The following article contains content from AppRiver. AppRiver could soon become even  more interesting for Swiss managed service providers. As AppRiver, in the next few weeks,  is very likely to be the first provider in Switzerland with Microsoft 365 on the market.

GULF BREEZE, Fla., May 17, 2018 (GLOBE NEWSWIRE) -- Microsoft 365 represents the fulfillment of Microsoft's longstanding vision to deliver an innovative portfolio of productivity, collaboration and security tools that address the future of business. It is the culmination of Microsoft's innovation, technology and forward strategy, and it will revolutionize how business users work and how administrators manage their IT infrastructure.

Microsoft looked deep into its crystal ball and saw how the modern workplace was drastically transforming. The future is cloud-based. It's mobile. It's global and dispersed. It's not tied to a formal office. And it's not secure.

For managed service providers (MSPs), consultants and resellers, Microsoft 365 presents a collection of enhanced business opportunities that will not only help to sell subscriptions, but also to educate clients and support the new infrastructure.
                                                            
Partners will need to develop a fluent understanding of the features, benefits and shortcomings of Microsoft 365 before making client presentations or recommendations. While Microsoft has generously provided a great deal of information on Microsoft 365, it can be a significant task to sort through the available assets and determine which are applicable.

Begin developing your knowledge of Microsoft 365 by understanding:

  • What Microsoft 365 encompasses
  • Key security considerations
  • New service and business opportunities

Microsoft 365: What's "In the Box"?
Many assume that Microsoft 365 is a new branding approach for the popular Office 365 suite of solutions. It isn't. Even at its most basic, Microsoft 365 is the applications, management tools and the operating system combined as one. It's a union that, at a glance, may seem unwieldy. However, its complexity is designed to transform the workplace for the better.

For partners, their clients and IT professionals, it is valuable to think of Microsoft 365 as a practice, not a product. While Microsoft 365 will have a significant impact on business users, it will be an entire shift in how IT administrators manage technology and their users. In turn, partners also need to take a different approach when presenting Microsoft 365 to clients.

Securing Microsoft 365
Microsoft 365 radically changes the security footprint and foundation. With Microsoft 365, all the pieces are working in concert and receive structured updates that are compatible with the entire stack. Among the many enhancements, Microsoft recognized that security can't be effectively addressed at only the enterprise or IT level, since end-users can infect the network with the click of a bad link. Therefore, Microsoft intelligently moved security to the user level and partners need to educate their clients on how to use these new tools.

Microsoft 365 outperforms legacy operating systems with a secure, modern state that extracts the best of Microsoft's new security capabilities. Moreover, while Microsoft 365 offers a wide range of security enhancements above and beyond Office 365, it will still require additional protections and will demand heightened monitoring and maintenance.

Microsoft 365: The Channel Opportunity
Beyond the opportunity to sell new subscriptions to customers, Microsoft 365 provides channel partners with a new opportunity to deliver ongoing service and support, along with the necessary hardware and security software that will power the next-generation, secure enterprise.

From a financial perspective, Microsoft 365 carries a higher perceived price point than Office 365, so gross margins will likely increase if partners apply the same markup methodology. Partners should expect a 10 - 18 percent increase in earnings over typical managed services.

Since Microsoft 365 is still new and there is much confusion in the market, partners can expect to receive many questions from clients. Some clients will also raise objections about the move to Microsoft 365 by attempting to hang on to current or legacy operating systems as long as possible.

Based on Microsoft's impassioned approach and the widespread benefits that Microsoft 365 will deliver, the upgrade to Microsoft 365 is essentially inevitable. It's not about if, it's when since many end-of-life (EOL) events are already scheduled to occur by the end of 2020. And while Microsoft has been known to extend EOL deadlines in the past, the transitions to Microsoft 365 and reseller opportunities will happen soon.

Next Steps: Getting Started
The need to get up-to-speed quickly on Microsoft 365's intricacies cannot be overstated. Few have time to sort through the bulk of Microsoft materials and extract the most actionable items, so it's helpful to locate materials, podcasts and videos that act as an "interpreter" to help decipher Microsoft's marketing language and support documentation for you and your customers.

There are also complimentary courses to help partners learn and sell Microsoft 365, some of which result in a certification medallion - a key element of validation that IT decision-makers will seek when selecting expert Microsoft 365 resellers.

Develop your knowledge, then get ready for the new era of opportunities with selling and supporting Microsoft's visionary new platform to IT decision-makers.

-----------------------------------
About the Author
Scott Paul is the Senior Director of AppRiver's Microsoft Alliance. AppRiver was one of the Microsoft's original go-to-market partners for Office 365 and now has one of the most experienced Office 365 support teams in the business. The company also provides free Microsoft 365 training courses for channel partners.
                                                       

CONTACT INFORMATION:

Jordi Vilanova
AppRiver
jvilanova@appriver.com
34-932-200-101 Ext 1002




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: AppRiver via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Karolinska Development's portfolio company Asarina Pharma is listed on Nasdaq First North24.9.2018 08:00Pressmeddelande

STOCKHOLM, 24 September 2018. Karolinska Development's portfolio company Asarina Pharma will today be listed on Nasdaq First North in Stockholm. In connection with the listing, Asarina Pharma is issuing 6.8 million shares. The issue price of SEK 21 gives Asarina Pharma a pre money valuation of SEK 172 million. Conditioned that the over-allotment option of an additional 0.35 million shares is fully exercised, Asarina Pharma will be provided with a total of SEK 150.2 million before issue costs. Asarina Pharma is a Swedish biotech company focused on chronic diseases associated with the menstrual cycle. The portfolio company is developing the drug candidate sepranolone as a treatment for premenstrual dysphoric disorder (PMDD) and premenstrual migraine. A Phase IIb study is currently underway in PMDD with expected completion by the end of 2019. Furthermore, Asarina Pharma is planning a clinical Phase IIa study in menstrual migraine for the first half of 2019. Karolinska Development is a pas

Karolinska Development's portfolio company Asarina Pharma is listed on Nasdaq First North24.9.2018 08:00Pressmeddelande

STOCKHOLM, 24 September 2018. Karolinska Development's portfolio company Asarina Pharma will today be listed on Nasdaq First North in Stockholm. In connection with the listing, Asarina Pharma is issuing 6.8 million shares. The issue price of SEK 21 gives Asarina Pharma a pre money valuation of SEK 172 million. Conditioned that the over-allotment option of an additional 0.35 million shares is fully exercised, Asarina Pharma will be provided with a total of SEK 150.2 million before issue costs. Asarina Pharma is a Swedish biotech company focused on chronic diseases associated with the menstrual cycle. The portfolio company is developing the drug candidate sepranolone as a treatment for premenstrual dysphoric disorder (PMDD) and premenstrual migraine. A Phase IIb study is currently underway in PMDD with expected completion by the end of 2019. Furthermore, Asarina Pharma is planning a clinical Phase IIa study in menstrual migraine for the first half of 2019. Karolinska Development is a pas

Immunicum AB (publ) meddelar att Pawel Kalinski och Inge Marie Svane har valts in i det vetenskapliga rådet17.9.2018 08:00Pressmeddelande

Pressmeddelande 17 september 2018 Immunicum AB (publ) meddelar att Pawel Kalinski och Inge Marie Svane har valts in i det vetenskapliga rådet Immunicum AB (publ; IMMU.ST) meddelade i dag att två ledande immun-onkologiska experter har valts in i bolagets vetenskapliga råd för att fungera som strategiska resurser för Immunicum under bolagets fortsatta kliniska utveckling av sin ledande produkt, ilixadencel. Pawel Kalinski, MD, PhD, vice ordförande för translationell forskning vid den medicinska institutionen vid Roswell Park Comprehensive Cancer Center, och Inge Marie Svane, MD, PhD, professor, chef för det kliniska cancerforskningsprogrammet på medicinska fakulteten vid Köpenhamns universitet, chef för Center för cancerimmunterapi (CCIT) samt överläkare inom onkologi, Herlevs universitetssjukhus har valts in i rådet. - Vi är hedrade att ha experter med specialistkompetens inom området immunonkologi och cellterapi i vårt vetenskapliga råd, vilka kan erbjuda ytterligare vägledning när det

Immunicum AB (publ) Announces Appointment of Pawel Kalinski and Inge Marie Svane to Scientific Advisory Board17.9.2018 08:00Pressmeddelande

Press Release 17 September 2018 Immunicum AB (publ) Announces Appointment of Pawel Kalinski and Inge Marie Svane to Scientific Advisory Board Immunicum AB (publ; IMMU.ST) announced today the appointment of leading oncology experts to its Scientific Advisory Board with the addition of Pawel Kalinski, MD, PhD, Vice Chair for Translational Research within the Department of Medicine at Roswell Park Comprehensive Cancer Center, and Inge Marie Svane, MD, PhD, Professor, Head of the Clinical Cancer Research programme, Faculty of Health Sciences, University of Copenhagen, Director, Centre for Cancer Immunotherapy (CCIT), and consultant in Oncology, Herlev University Hospital. Both Scientific Advisory Board members will serve as a strategic resource to Immunicum as the company continues to advance the clinical development of its lead product, ilixadencel. "We are honored to have such highly specialized experts in the field of immuno-oncology and cell therapy join our Scientific Advisory Board a

Hoylu AB: HOYLU HIRES NEW CTO, SATOSHI NAKAJIMA AND ANNOUNCES EXPANSION INTO JAPAN14.9.2018 08:30Pressmeddelande

Malmo, Sweden, September 14, 2018 - Hoylu, a leading enterprise collaboration company, announced today Satoshi Nakajima will join Hoylu in the newly created position, as Chief Technology Officer and President of Hoylu Japan. Nakajima will guide the strategic technology direction and innovation of Hoylu while also leading the new Hoylu office in Tokyo, Japan. "Satoshi is a visionary and world-class technologist who has substantial experience in delivering world class innovations. He is joining the Company as we are extending our reach and expanding into Japan," said Stein Revelsby, CEO. "Satoshi's extensive experience in strategy and delivering technology that support a great user experience will make an immediate impact on the company." Nakajima will serve as President of Hoylu Japan and will report to Stein Revelsby. His leadership will strengthen customer relations and help develop new business among emerging and established Japanese companies while strengthening the global position

Hoylu AB: HOYLU ANSTÄLLER SATOSHI NAKAJIMA SOM NY CTO OCH EXPANDERAR TILL JAPAN14.9.2018 08:30Pressmeddelande

Malmö, Sverige, 14 september 2018 - Hoylu, ett ledande företag inom samarbetsmjukvara för företagsmarknaden annonserar idag att Satoshi Nakajima tar anställning som CTO (Chief Technology Officer) och President för Hoylu Japan. Nakajima kommer styra den strategiska inriktningen för företagets produkter och leda innovationsarbetet. Han kommer också leda Hoylus nyöppnade kontor i Tokyo, Japan. Satoshi är en visionär teknologiexpert som har stor erfarenhet av att skapa innovativa lösningar. Han kommer till Hoylu samtidigt som vi utökar marknaden till att även täcka in Japan säger Stein Revelsby, VD. "Satoshis långa och gedigna erfarenhet i strategiska frågor och tekniska lösningar med fokus på användarupplevelse kommer få stor betydelse för oss." Nakajima kommer även att bli President för Hoylu Japan och kommer rapportera till Stein Revelsby. Hans ledarskap kommer stärka existerande kundrelationer och utveckla nya affärer på den japanska marknaden och samtidigt bidra till att flytta fram p

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum